PFKFB3 Regulates Cancer Stemness through the Hippo Pathway in Small Cell Lung Carcinoma

Researchers found that PFK158 treatment and PFKFB3 knockdown enhanced the ABCG2-interacting drugs doxorubicin, etoposide, and 5-fluorouracil in reducing cell viability under conditions of enriched CSCs.